Abstract
Rationale: Dexmedetomidine (DEX) is an α2-agonist used as an intravenous sedative agent in the intensive care setting. In certain cases, simultaneous administration of DEX and total parenteral nutrition (TPN) may be required. The aim of this study was to evaluate the physicochemical compatibility of DEX with TPN during simulated Y-site administration.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
